• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于新型肿瘤芽生和细胞巢大小的分级系统在外阴鳞状细胞癌中优于传统方法。

A novel tumor budding and cell nest size-based grading system outperforms conventional methods in vulvar squamous cell carcinoma.

作者信息

Chen Xiangyu, Song Shuang, Shi Haiyan, Lu Bingjian

机构信息

Department of Surgical Pathology, Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang Province, China.

Department of Surgical Pathology, Zhejiang Provincial Traditional Chinese Medicine Hospital, Hangzhou, Zhejiang Province, China.

出版信息

Virchows Arch. 2025 May 10. doi: 10.1007/s00428-025-04123-4.

DOI:10.1007/s00428-025-04123-4
PMID:40347267
Abstract

The tumor budding and tumor cell nest size-based (TBNS) grading scheme is an emerging prognostic indicator for squamous cell carcinoma (SCC) across various organs; however, its significance in vulvar SCC (VSCC) remains poorly investigated. In this study, we applied the TBNS grading system to an institutional cohort of 62 consecutive surgically resected VSCC cases (39 HPV-independent and 23 HPV-associated), excluding patients with neoadjuvant chemotherapy or FIGO stage IA disease. High tumor budding activity, small cell nest size, and high TBNS grade were significantly associated with reduced overall survival (OS) and disease-free survival (DFS) in VSCC, as well as with adverse clinicopathologic features such as lymphovascular space invasion, perineural involvement, lymph node metastasis, and advanced FIGO stage (p < 0.05). Multivariate analysis revealed that TBNS grade 3 was independently associated with reduced DFS (p < 0.05). In contrast, among the two conventional grading systems, only the Gynecology Oncology Group grading system showed a significant association with OS in univariate analysis (p < 0.05), but not in multivariate analysis (p > 0.05). We conclude that the TBNS grading system is a promising prognostic indicator for VSCC, outperforming conventional grading systems. Further validation in larger cohorts is needed to expand the clinical applicability of this grading system in VSCC.

摘要

基于肿瘤芽生和肿瘤细胞巢大小(TBNS)的分级方案是一种新兴的跨器官鳞状细胞癌(SCC)预后指标;然而,其在外阴鳞状细胞癌(VSCC)中的意义仍研究不足。在本研究中,我们将TBNS分级系统应用于一个机构队列,该队列包含62例连续接受手术切除的VSCC病例(39例HPV非依赖性和23例HPV相关性),排除接受新辅助化疗或FIGO IA期疾病的患者。高肿瘤芽生活性、小细胞巢大小和高TBNS分级与VSCC患者的总生存期(OS)和无病生存期(DFS)降低显著相关,也与诸如淋巴血管间隙浸润、神经周围侵犯、淋巴结转移和晚期FIGO分期等不良临床病理特征相关(p<0.05)。多因素分析显示,TBNS 3级与DFS降低独立相关(p<0.05)。相比之下,在两种传统分级系统中,只有妇科肿瘤学组分级系统在单因素分析中显示与OS显著相关(p<0.05),但在多因素分析中无显著相关性(p>0.05)。我们得出结论,TBNS分级系统是VSCC一种有前景的预后指标,优于传统分级系统。需要在更大队列中进一步验证,以扩大该分级系统在VSCC中的临床应用。

相似文献

1
A novel tumor budding and cell nest size-based grading system outperforms conventional methods in vulvar squamous cell carcinoma.一种基于新型肿瘤芽生和细胞巢大小的分级系统在外阴鳞状细胞癌中优于传统方法。
Virchows Arch. 2025 May 10. doi: 10.1007/s00428-025-04123-4.
2
Further confirmation of a highly prognostic grading scheme based upon tumour budding and cell cluster size in cervical squamous cell carcinoma.基于肿瘤芽生和细胞簇大小的宫颈鳞状细胞癌高预后分级方案的进一步确认。
Histopathology. 2025 May;86(6):967-978. doi: 10.1111/his.15404. Epub 2024 Dec 27.
3
Independent Validation of Tumor Budding Activity and Cell Nest Size as Determinants of Patient Outcome in Squamous Cell Carcinoma of the Uterine Cervix.肿瘤芽殖活性和细胞巢大小作为子宫颈鳞状细胞癌患者预后的决定因素的独立验证。
Am J Surg Pathol. 2020 Sep;44(9):1151-1160. doi: 10.1097/PAS.0000000000001472.
4
Tumor Budding as an Independent Prognostic Histopathological Marker in Oral Squamous Cell Carcinoma - An Indian Tertiary Care Center Experience.肿瘤芽生作为口腔鳞状细胞癌独立的预后组织病理学标志物——印度三级医疗中心的经验
Turk Patoloji Derg. 2025;41(2):31-41. doi: 10.5146/tjpath.2025.13761.
5
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
6
Prognostic factors for local recurrence of squamous cell carcinoma of the vulva: A systematic review.外阴鳞癌局部复发的预后因素:系统评价。
Gynecol Oncol. 2018 Mar;148(3):622-631. doi: 10.1016/j.ygyno.2017.11.006. Epub 2017 Nov 12.
7
Prognostic role of perineural invasion in vulvar squamous cell carcinoma: A systematic review and meta-analysis.神经周围浸润在外阴鳞状细胞癌中的预后作用:一项系统评价和荟萃分析。
Eur J Surg Oncol. 2022 Dec;48(12):2354-2359. doi: 10.1016/j.ejso.2022.06.031. Epub 2022 Jun 25.
8
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
9
Optimal primary surgical treatment for advanced epithelial ovarian cancer.晚期上皮性卵巢癌的最佳初次手术治疗
Cochrane Database Syst Rev. 2011 Aug 10;2011(8):CD007565. doi: 10.1002/14651858.CD007565.pub2.
10
The prognostic role of FIGO stage in patients with vulvar cancer: a systematic review and meta-analysis.国际妇产科联盟(FIGO)分期在外阴癌患者中的预后作用:一项系统评价和荟萃分析。
Curr Med Res Opin. 2016 Jun;32(6):1121-30. doi: 10.1185/03007995.2016.1162147. Epub 2016 Apr 5.

本文引用的文献

1
Further confirmation of a highly prognostic grading scheme based upon tumour budding and cell cluster size in cervical squamous cell carcinoma.基于肿瘤芽生和细胞簇大小的宫颈鳞状细胞癌高预后分级方案的进一步确认。
Histopathology. 2025 May;86(6):967-978. doi: 10.1111/his.15404. Epub 2024 Dec 27.
2
Tumor budding in pre-neoadjuvant biopsy and post-neoadjuvant resection specimens is associated with poor prognosis in intrahepatic cholangiocarcinoma-a cohort study of 147 cases by modified ITBCC criteria.肿瘤在新辅助活检和新辅助切除标本中的芽生与肝内胆管癌的不良预后相关——改良 ITBCC 标准的 147 例病例队列研究。
Virchows Arch. 2024 Nov;485(5):913-923. doi: 10.1007/s00428-024-03937-y. Epub 2024 Oct 10.
3
Tumour budding as a prognostic biomarker in biopsies and resections of neoadjuvant-treated rectal adenocarcinoma.
肿瘤芽作为新辅助治疗直肠腺癌活检和切除标本的预后生物标志物。
Histopathology. 2024 Aug;85(2):224-243. doi: 10.1111/his.15192. Epub 2024 Apr 17.
4
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.2022 年全球癌症统计数据:全球 185 个国家和地区 36 种癌症的发病率和死亡率全球估计数。
CA Cancer J Clin. 2024 May-Jun;74(3):229-263. doi: 10.3322/caac.21834. Epub 2024 Apr 4.
5
Lymphovascular invasion and p16 expression are independent prognostic factors in stage I vulvar squamous cell carcinoma.淋巴管血管侵犯和 p16 表达是Ⅰ期外阴鳞癌的独立预后因素。
Virchows Arch. 2024 Jun;484(6):951-963. doi: 10.1007/s00428-023-03670-y. Epub 2023 Oct 16.
6
Human papillomavirus and p53 status define three types of vulvar squamous cell carcinomas with distinct clinical, pathological, and prognostic features.人乳头瘤病毒和 p53 状态定义了三种具有不同临床、病理和预后特征的外阴鳞状细胞癌。
Histopathology. 2023 Jul;83(1):17-30. doi: 10.1111/his.14925. Epub 2023 Apr 26.
7
Data Set for the Reporting of Carcinomas of the Vulva: Recommendations From the International Collaboration on Cancer Reporting (ICCR).外阴癌报告数据集:国际癌症报告合作组织(ICCR)的建议。
Int J Gynecol Pathol. 2022 Nov 1;41(Suppl 1):S8-S22. doi: 10.1097/PGP.0000000000000900. Epub 2022 Oct 10.
8
Trends in HPV- and non-HPV-associated vulvar cancer incidence, United States, 2001-2017.人乳头瘤病毒(HPV)相关和非 HPV 相关外阴癌发病率趋势,美国,2001-2017 年。
Prev Med. 2022 Nov;164:107302. doi: 10.1016/j.ypmed.2022.107302. Epub 2022 Oct 12.
9
Evaluation of the Cellular Dissociation Grading, Based on Tumor Budding and Cell Nest Size, in Squamous Cell Carcinoma of the Penis.基于肿瘤芽生和细胞巢大小的阴茎鳞状细胞癌的细胞解离分级评估
Cancers (Basel). 2022 Oct 9;14(19):4949. doi: 10.3390/cancers14194949.
10
Prognostic impact of tumour budding in squamous cell carcinoma of the lung: a systematic review and meta-analysis.肿瘤芽生对肺鳞状细胞癌的预后影响:一项系统评价和荟萃分析
Histopathology. 2023 Mar;82(4):521-530. doi: 10.1111/his.14822. Epub 2022 Oct 26.